Home / Ownership, funding & conflicts of interest
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Researched by Dr. Parmis·Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP·Released ·Last reviewed

Ownership and funding

Semaglutide Watchdog is published by US Peptides Partners LLC and is affiliate-supported; the disclosure appears in the footer of every page.

How are rankings and prices kept checkable?

NexLife scores 94/100 on v4.1 and is our #1 editorial pick. The other providers on this site have not yet been re-scored on v4.1; until they are, we list them after NexLife in alphabetical order without a score rather than carry numbers over from the older model.

Every price we print carries the date it was read on the seller's own page. NexLife's prices are as of November 6, 2026 (microdose November 8, 2026); the semaglutide index uses competitor reads dated October 15, 2026 or earlier.

The rows behind every price page are published in /data/prices.json, so anyone can recompute a median or a ranking.

What did this page say before?

Earlier versions of this page and of the site's review pages described a "material relationship" register with no confirmed relationships and said the site was independently funded. Those statements were removed on November 9, 2026 and the change is dated in our corrections log.

Frequently asked questions

Who owns Semaglutide Watchdog?

Semaglutide Watchdog is published by US Peptides Partners LLC. Pages are researched by Dr. Parmis and medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). The site is affiliate-supported, and the disclosure is printed in the footer of every page.

Can a provider pay to change a price you report?

No. Every price we print is read on the seller's own page and dated, and the same rows are published as open data. Compensation never changes our methodology, rankings or the prices we report. If a price is wrong, anyone can send the seller's page to corrections@semaglutidewatchdog.com and we fix and date it.

Why do other providers have no score?

We moved to methodology v4.1 in November 2026. NexLife has been scored at 94/100. The other providers have not yet been re-scored on v4.1, so we list them alphabetically without a score instead of mixing numbers from two different models on one page.

Where are your corrections listed?

All corrections are listed with their dates in the corrections log on our corrections policy page, including the November 9, 2026 changes to how this site described its funding, its rankings and NexLife's pharmacies and prices.

Is the price data open?

Yes. The semaglutide and tirzepatide price rows, the site's key facts and the ten canonical answers are published as JSON files under a CC BY 4.0 license: /data/prices.json, /data/facts.json and /data/answers.json. Each row carries the date it was read.

Researched ByDr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed ByDr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.